GCM
TMO icon

Gladius Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Gladius Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,710
Closed -$2.05M – 350
2024
Q2 		$2.05M Buy
3,710
+2,944
+384% +$1.69M 0.25% 47
2024
Q1 		$445K Buy
+766
New +$430K 0.15% 102
2023
Q4 		– Sell
-5,636
Closed -$2.73M – 410
2023
Q3 		$2.85M Buy
5,636
+5,270
+1,440% +$2.81M 0.12% 106
2023
Q2 		$191K Buy
366
+265
+262% +$143K 0.01% 140
2023
Q1 		$58.2K Sell
101
-549
-84% -$309K ﹤0.01% 206
2022
Q4 		$358K Sell
650
-3,999
-86% -$2.12M 0.03% 116
2022
Q3 		$2.36M Buy
+4,649
New +$2.6M 0.1% 79
2022
Q2 		– Sell
-124
Closed -$74K – 424
2022
Q1 		$74K Sell
124
-494
-80% -$284K 0.01% 251
2021
Q4 		$413K Buy
+618
New +$386K 0.03% 124
2021
Q3 		– Sell
-51
Closed -$28K – 135
2021
Q2 		$26K Sell
51
-2,819
-98% -$1.33M ﹤0.01% 123
2021
Q1 		$1.31M Buy
2,870
+885
+45% +$422K 0.05% 132
2020
Q4 		$925K Buy
1,985
+1,416
+249% +$664K 0.05% 144
2020
Q3 		$252K Buy
+569
New +$235K 0.03% 158
2019
Q4 		– Sell
-142
Closed -$43.1K – 205
2019
Q3 		$42K Buy
+142
New +$40.7K ﹤0.01% 204

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Gladius Capital Management's TMO Position: Q3 2024 in Review

Gladius Capital Management sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 3,710 shares — an estimated $2.05M sold.

Gladius Capital Management first reported a position in TMO in Q3 2019 and held it in 14 quarters. The position peaked at $2.85M in Q3 2023. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • Gladius Capital Management reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
  • Gladius Capital Management sold 3,710 Thermo Fisher Scientific shares in Q3 2024, an estimated $2.05M.
  • Gladius Capital Management first reported a position in Thermo Fisher Scientific in Q3 2019 and held it in 14 quarters.
  • Gladius Capital Management's Thermo Fisher Scientific position peaked at $2.85M in Q3 2023.
  • 2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Gladius Capital Management's 13F filing for Q3 2024, filed 6 Nov 2024.